Takada, Sae <br/><br/>
Reducing cardiovascular risk among people living with HIV: Rationale and design of the INcreasing Statin Prescribing in HIV Behavioral Economics REsearch (INSPIRE) randomized controlled trial.  [electronic resource] 

 -  Progress in cardiovascular diseases   
 - 109-117 p.  digital 
<br/><br/> Publication Type: Clinical Trial Protocol; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1873-1740 
<br/><br/><label>Standard No.: </label>10.1016/j.pcad.2020.02.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-HIV Agents--adverse effects<br/>Attitude of Health Personnel<br/>Cardiovascular Diseases--diagnosis<br/>Drug Prescriptions<br/>Economics, Behavioral<br/>Education, Medical, Continuing<br/>HIV Infections--diagnosis<br/>HIV Long-Term Survivors--psychology<br/>Health Knowledge, Attitudes, Practice<br/>Health Status<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Implementation Science<br/>Inservice Training<br/>Los Angeles--epidemiology<br/>Medication Adherence<br/>Multicenter Studies as Topic<br/>Patient Education as Topic<br/>Practice Patterns, Physicians'<br/>Preventive Health Services<br/>Protective Factors<br/>Randomized Controlled Trials as Topic<br/>Risk Assessment<br/>Risk Factors<br/>Time Factors<br/>Treatment Outcome<br/>Viral Load